Furthermore, some missense variants may exhibit partially reduced activity sufficient to confer a moderately increased risk of breast cancer, as shown for R1699N substitution in BRCA1 or Y3035S in BRCA2 [45]. Here, BRCA2 is linked to breast cancer.